Switch to:
Array BioPharma Inc (NAS:ARRY)
Revenue
$33.92 Mil (TTM As of Sep. 2014)

Array BioPharma Inc's revenue for the three months ended in Sep. 2014 was $6.07 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2014 was $33.92 Mil. Array BioPharma Inc's revenue per share for the three months ended in Sep. 2014 was $0.05. Its revenue per share for the trailing twelve months (TTM) ended in Sep. 2014 was $0.27 Mil.

Warning Sign:

Array BioPharma Inc revenue has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Array BioPharma Inc was -55.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -36.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was -25.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was -7.00% per year.

During the past 13 years, Array BioPharma Inc's highest 3-Year average Revenue per Share Growth Rate was 39.40% per year. The lowest was -36.00% per year. And the median was -2.70% per year.


Definition

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Array BioPharma Inc Revenue for the trailing twelve months (TTM) ended in Sep. 2014 was 14.066 (Dec. 2013 ) + 7.773 (Mar. 2014 ) + 6.011 (Jun. 2014 ) + 6.069 (Sep. 2014 ) = $33.92 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


• Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
• Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
• Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Related Terms

Net Income, Cost of Goods Sold, Operating Income, Pre-Tax Income


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma Inc Annual Data

Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14
Revenue 45.5145.0036.9728.8124.9853.8871.9085.1469.5842.08

Array BioPharma Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
Revenue 20.6615.8318.389.9625.4214.2314.077.776.016.07
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK